Number of active disease-modifying Alzheimer's drug trials globally in 2019, by phase

Published by
Matej Mikulic,
Jun 3, 2022
This statistic depicts the number of currently active novel disease-modifying clinical trials for Alzheimer's disease drugs globally as of February 2019, by phase. At that time there were 34 active clinical trials for novel disease-modifying Alzheimer's drugs in phase II.

Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase*

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

May 2019

Region

Worldwide

Survey time period

February 28, 2019

Supplementary notes

* Twelve programs listed as “Ex-US” in the Biomedtracker database are included here by phase based on independent research of company websites. This “Ex-US” listing implies the companies have not yet intended to seek FDA approval. No NDA/BLA filings were active for Alzheimer’s Disease as of February 28, 2019. Only novel approaches with disease modifying potential in Alzheimer’s disease are shown.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Dementia and Alzheimer's disease in Europe "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Dementia and Alzheimer's disease in Europe

World overview

6

European focus

5

Mortality and morbidity

8

Situation in specific countries

8

Policies directed towards dementia

8

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Dementia and Alzheimer's disease in EuropeDementia and Alzheimer's disease in the United StatesLong-term care in the U.S.Mental health in Europe
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.